Skip to content

Prospective Registry to Assess the Cath Lab Percutaneous Coronary Intervention Long-term Outcomes: a Single Center

Prospective Registry to Assess the Cath Lab Percutaneous Coronary Intervention Long-term Outcomes: a Single Center

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02498470
Acronym
PCI-registry
Enrollment
10000
Registered
2015-07-15
Start date
2008-01-31
Completion date
2017-12-31
Last updated
2016-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The registry study is to obtain the state of the percutaneous coronary intervention state treatment for coronary heart disease in the center of the first hospital of sun yat-sen unversity in a real world.

Detailed description

The registry study is to obtain the long-term outcomes of the percutaneous coronary intervention state treatment for coronary heart disease patients in the center of the first hospital of sun yat-sen unversity in a real world. The data are collected using an uploading system through internet.

Interventions

PROCEDUREpercutaneous coronary intervention

All the patients receiving coronal artery angiography or percutaneous coronary intervention therapy by standard protocol

Sponsors

Xiao-dong Zhuang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients receiving coronal artery angiography or percutaneous coronary intervention therapy

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Composite Major Adverse Cardiac Events (MACE)5 yearsAll death All death, myocardial infarction, revascularization

Secondary

MeasureTime frameDescription
Target Lesion Failure5 yearcomposite target lesion failure (TLF) defined as a composite of cardiac death, non-fatal myocardial infarction (MI) not clearly attributable to a nontarget vessel, or target lesion revascularization (TLR) (percutaneous or by coronary artery bypass grafting)

Countries

China

Contacts

Primary Contactxiaodong zhuang, MD,PhD
zxd_medicine@163.com+8602087332200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026